SYNTHESIS AND CHARACTERIZATION OF STARCH MALONATE: DEVELOPMENT OF FAST DISSOLVING TABLETS OF ACECLOFENAC BY 23 FACTORIAL DESIGNS

Authors

  • ANNU KUMARI Gitam Institute of Pharmacy, Gitam (Deemed to be University), Rushikonda, Visakhapatnam, A. P. 530045, India
  • R. SANTOSH KUMAR Gitam Institute of Pharmacy, Gitam (Deemed to be University), Rushikonda, Visakhapatnam, A. P. 530045, India

DOI:

https://doi.org/10.22159/ijap.2021v13i3.40538

Keywords:

Fast dissolving tablets, Superdisintegrant, Starch malonate, Aceclofenac, Dissolution efficiency

Abstract

Objective: The aim of the research work is to develop a new superdisintegrant (starch malonate) which can help in enhancing the solubility and drug dissolution of poorly soluble drugs. Hence, starch malonate (new superdisintegrant) was prepared and has been evaluated for its superdisintegrant property by incorporating it into fast dissolving tablets of Aceclofenac.

Methods: Superdisintegrant was developed by using esterification reaction. Prepared starch malonate was then subjected for different characterization tests (solubility, pH, melting point, swelling index, FTIR, DSC studies. 23 factorial design method was used to formulate fast dissolving tablets of aceclofenac employing starch malonate. Two known superdisintegrants croscarmellose sodium and crospovidone have been used along with starch malonate in combinations to develop fast dissolving tablets. Prepared tablets were then subjected to different tests for tablets like hardness, friability, disintegration time, dissolution studies. A stability study was performed to determine the stability of the formulation. Design expert study was conducted to know the interaction between different superdisintegrants and to select best optimized formulation in among all formulations.

Results: Starch malonate prepared was found to be fine, free flowing slightly crystalline powder, insoluble in aqueous and organic solvents. Tablets of all formulations were of excellent quality concerning drug content (100±5%), hardness (3.8-4.2 kg/cm2), and friability (less than 0.15%). In all formulations, formulation F2 found to be optimized formulation with least disintegration time 38 S, less wetting time 17±0.08 s and enhanced percent dissolved rate in 5 min i.e., 99.84% as compared to other formulations.

Conclusion: From this it was concluded that starch malonate can be used as a novel superdisintegrant to enhance the drug dissolution of poorly soluble drugs. Optimized formulation F2 showed enhanced drug dissolution at 5% concentration as compared to other formulation and showed least disintegration time and enhanced drug dissolution as compared to other formulations and pure drug.

References

Ashish Masih, Amar Kumar, Shivam Singh, Ajay Kumar Tiwari. Fast dissolving tablets: a review. Int J Curr Pharm Res 2017;9:8-18.

Pratik Swarup Das, Sushma Verma, Puja Saha. Fast dissolving tablet using solid dispersion technique: a review. Int J Curr Pharm Res 2017;9:1-4.

T Gulsun, N Ozturk, MS Kaynak, I Vural, S Sahin. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression. Pharmazie 2017;72:389-94.

Prateek Juneja, Birender Kaur, Oluwatoyin A Odeku, Inderbir Singh. Development of corn starch-neusilin UFL2 conjugate as tablet superdisintegrant: formulation and evaluation of fast disintegrating tablets. J Drug Delivery 2014. https://doi.org/10.1155/2014/827035

Inderbir Singh, Birender Kaur, Prateek Juneja Olim. Preparation and characterization of starch-metal silicate co-precipitates--evaluation as tablet superdisintegrant. Med 2014;44:157–66.

Inderbir Singh, Bhawna Sharma, Govind Arora. Application of SeDeM expert system in formulation and development of fast disintegrating tablets using starch-glycine conjugates as superdisintegrant. J Res Pharm 2019;23:839-50.

R Santosh Kumar, T Naga Satya Yagnesh, V Goutham Kumar. Optimisation of ibuprofen fast dissolving tablets employing starch Xanthate using 23factorial design. Int J Appl Pharm 2017;9:51-5.

Santosh Kumar R, Annu Kumari. Design, optimization, and evaluation of acyclovir fast dissolving tablets employing starch phthalate–a novel superdisintegrant. Asian J Pharm Clin Res 2019;12:132-42.

Santosh Kumar R, Sahithi Mudili. Formulation and evaluation of statistically designed ibuprofen fast-dissolving tablets employing starch glutamate as a novel superdisintegrant. Asian J Pharm Clin Res 2019;12:85-94.

Nadia H Naiem, Ebtessam A Essa, Gamal M Elmaghraby. Enhancing dissolution rate of indomethacin by in situ crystalization; development of orally disintegrating tablets. Int J Pharm Sci 2018;10:18-23.

Dattatraya M Shinkar, Pooja S Aher, Parag D Kothawade, Avish D Maru. Formulation and in vitro evaluation of fast dissolving tablet of verapamil hydrochloride. Int J Pharm Sci 2018;10:93-9.

Milind P Wagh, Chetan P Vewale, Santosh U Zate, Paresh I Kothawade, Ganesh H Mahale. Formulation and evaluation of fast dispersible tablets of aceclofenac using different superdisintegrant. Int J Pharm Pharm Sci 2010;2:154-7.

KPR Chowdary, S Gopinath, C Uma Maheswara Reddy, S Umamaheswari. Factorial studies on formulation development of aceclofenac tablets employing β cyclodextrin and kolliphor HS15. World J Pharm Res 2015;3:1088-97.

Lovleen Kaur, Rajni Bala, Neha Kanojia, Manju Nagpal, Gitika Arora Dhingra. Formulation development and optimization of fast dissolving tablets of aceclofenac using natural superdisintegrant. ISRN Pharmaceutics 2014. DOI:10.1155/2014/242504

R Santosh Kumar, Sahithi Mudili. Optimization of statistically designed aceclofenac fast dissolving tablets employing starch glutamate as a novel superdisintegrant. Int J Appl Pharm 2020;12:77-88.

Jahan Nur Rahman Hazarika, Pulak Deb. Formulation evaluation and optimization of immediate release tablet of aceclofenac by direct compression method. Int J Curr Pharm Res 2017;9:118-22.

Published

2021-05-07

How to Cite

KUMARI, A., & KUMAR, R. S. (2021). SYNTHESIS AND CHARACTERIZATION OF STARCH MALONATE: DEVELOPMENT OF FAST DISSOLVING TABLETS OF ACECLOFENAC BY 23 FACTORIAL DESIGNS. International Journal of Applied Pharmaceutics, 13(3), 87-102. https://doi.org/10.22159/ijap.2021v13i3.40538

Issue

Section

Original Article(s)